MEDEXUS PHARMACEUTICALS INC (MDP.CA) Stock Earnings Estimates
TSX:MDP • CA58410Q2036
2.88 CAD
0 (0%)
Last: Feb 27, 2026, 07:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 108.096M 40.93% | 113.054M 4.59% | 108.332M -4.18% | 100.9M -6.86% | 119.32M 18.26% | 137.09M 14.89% | 164.43M 19.94% | 187.83M 14.23% | 213.74M 13.79% | 224.7M 5.13% | 236.45M 5.23% | |
| EBITDA YoY % growth | 14.57M 333.83% | 18.593M 27.61% | 19.099M 2.72% | 16.034M -16.05% | 22.139M 38.08% | 39.918M 80.31% | 53.289M 33.50% | 66.963M 25.66% | 58.928M -12.00% | 65.351M 10.90% | 72.348M 10.71% | |
| EBIT YoY % growth | 8.489M 168.59% | 12.787M 50.63% | 11.921M -6.77% | 4.513M -62.14% | 9.089M 101.40% | 25.176M 176.99% | 46.195M 83.49% | 61.512M 33.16% | 53.248M -13.43% | 53.552M 0.57% | N/A | |
| Operating Margin | 7.85% | 11.31% | 11.00% | 4.47% | 7.62% | 18.36% | 28.09% | 32.75% | 24.91% | 23.83% | N/A | |
| EPS YoY % growth | -0.05 96.06% | -0.01 80.00% | 0.08 900.00% | -0.07 -188.38% | 0.20 385.71% | 0.44 120.00% | 0.65 45.50% | 0.68 4.70% | 0.63 -7.47% | 0.60 -4.85% | N/A |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.02 32.67% | 0.07 253.50% | 0.15 1,615.00% |
| Revenue Q2Q % growth | 25.842M 4.40% | 26.866M 9.14% | 31.058M 25.53% |
| EBITDA Q2Q % growth | 3.489M -49.35% | 3.838M 17.16% | 6.565M 0.89% |
| EBIT Q2Q % growth | 572.67K 297.47% | 808K -4.94% | 5.05M 205.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2026 Q2Q % growth | 0.00 -90.00% | -0.04 | 0.04 | 107.43% |
| Q2 2026 Q2Q % growth | -0.01 | -0.01 | 0.00 | 0.99% |
| Q1 2026 Q2Q % growth | 0.02 -75.00% | -0.05 | 0.07 | 144.00% |
| Q4 2025 Q2Q % growth | -0.03 -200.00% | -0.07 | 0.04 | 58.46% |
| Q3 2025 Q2Q % growth | 0.03 250.00% | 0.02 | 0.01 | 69.73% |
| Q2 2025 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | -100.00% |
| Q1 2025 Q2Q % growth | 0.08 166.67% | 0.04 | 0.04 | 98.02% |
| Q4 2024 Q2Q % growth | 0.03 -91.18% | -0.02 | 0.05 | 248.51% |
| Q3 2024 Q2Q % growth | -0.02 71.43% | 0.03 | -0.05 | -158.24% |
| Q2 2024 Q2Q % growth | -0.05 64.29% | 0.02 | -0.07 | -325.02% |
| Q1 2024 Q2Q % growth | 0.03 116.67% | -0.01 | 0.04 | 354.52% |
| Q4 2023 Q2Q % growth | 0.34 225.93% | -0.06 | 0.40 | 712.06% |
| Q3 2023 Q2Q % growth | -0.07 58.82% | -0.08 | 0.01 | 13.37% |
| Q2 2023 Q2Q % growth | -0.14 56.25% | -0.14 | 0.00 | 0.99% |
| Q1 2023 Q2Q % growth | -0.18 64.67% | -0.14 | -0.04 | -27.30% |
| Q4 2022 Q2Q % growth | -0.27 57.12% | -0.22 | -0.05 | -23.38% |
| Q3 2022 Q2Q % growth | -0.17 81.23% | -0.30 | 0.13 | 42.94% |
| Q2 2022 Q2Q % growth | -0.32 -898.84% | -0.26 | -0.06 | -21.36% |
| Q1 2022 Q2Q % growth | -0.51 -113.94% | -0.03 | -0.48 | -1,490.43% |
| Q4 2021 Q2Q % growth | -0.63 -463.99% | -0.02 | -0.61 | -3,843.42% |
| Q3 2021 Q2Q % growth | -0.91 -2,888.88% | 0.03 | -0.94 | -2,927.74% |
| Q2 2021 Q2Q % growth | -205.73% | -0.03 | % | |
| Q1 2021 Q2Q % growth | -0.24 -112.36% | 0.02 | -0.26 | -1,196.75% |
| Q4 2020 Q2Q % growth | -0.11 | -0.06 | -0.05 | -77.95% |
| Q3 2020 Q2Q % growth | -0.03 | -0.06 | 0.03 | 53.23% |
| Q2 2020 Q2Q % growth | 0.03 | -0.04 | 0.07 | 185.06% |
| Q1 2020 Q2Q % growth | -0.11 | -0.10 | -0.01 | -8.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2026 Q2Q % growth | 25.324M -15.56% | 25.398M | -74K | -0.29% |
| Q2 2026 Q2Q % growth | 24.741M -5.94% | 25.831M | -1.09M | -4.22% |
| Q1 2026 Q2Q % growth | 24.615M -9.78% | 24.77M | -155K | -0.63% |
| Q4 2025 Q2Q % growth | 24.754M -4.65% | 24.863M | -109K | -0.44% |
| Q3 2025 Q2Q % growth | 29.992M 18.96% | 28.078M | 1.914M | 6.82% |
| Q2 2025 Q2Q % growth | 26.303M -13.27% | 26.405M | -102K | -0.39% |
| Q1 2025 Q2Q % growth | 27.283M -13.54% | 27.186M | 97K | 0.36% |
| Q4 2024 Q2Q % growth | 25.962M -9.33% | 27.026M | -1.064M | -3.94% |
| Q3 2024 Q2Q % growth | 25.211M -12.25% | 30.661M | -5.45M | -17.78% |
| Q2 2024 Q2Q % growth | 30.326M 9.54% | 30.658M | -332K | -1.08% |
| Q1 2024 Q2Q % growth | 31.555M 36.92% | 29.288M | 2.267M | 7.74% |
| Q4 2023 Q2Q % growth | 28.633M 41.31% | 28.497M | 136K | 0.48% |
| Q3 2023 Q2Q % growth | 28.731M 35.08% | 28.824M | -93K | -0.32% |
| Q2 2023 Q2Q % growth | 27.686M 54.66% | 24.846M | 2.84M | 11.43% |
| Q1 2023 Q2Q % growth | 23.046M 33.47% | 22.018M | 1.028M | 4.67% |
| Q4 2022 Q2Q % growth | 20.263M 775.43% | 18.658M | 1.605M | 8.60% |
| Q3 2022 Q2Q % growth | 21.27M -32.50% | 18.831M | 2.439M | 12.95% |
| Q2 2022 Q2Q % growth | 17.901M -24.24% | 18.093M | -192K | -1.06% |
| Q1 2022 Q2Q % growth | 17.267M -37.26% | 19.785M | -2.518M | -12.73% |
| Q4 2021 Q2Q % growth | -3M -111.71% | 21.72M | -24.72M | -113.81% |
| Q3 2021 Q2Q % growth | 31.51M 94.51% | 25.277M | 6.233M | 24.66% |
| Q2 2021 Q2Q % growth | 23.63M 44.09% | 19.785M | 3.845M | 19.43% |
| Q1 2021 Q2Q % growth | 27.52M 70.61% | 19.985M | 7.535M | 37.70% |
| Q4 2020 Q2Q % growth | 25.63M | 14.361M | 11.269M | 78.47% |
| Q3 2020 Q2Q % growth | 16.2M | 13.198M | 3.002M | 22.75% |
| Q2 2020 Q2Q % growth | 16.4M | 13.858M | 2.542M | 18.34% |
| Q1 2020 Q2Q % growth | 16.13M | 12.06M | 4.07M | 33.75% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 50% | -233.33% | 0% | -460% |
| Revenue | -0.9% | -2.29% | -0.52% | -2.95% |